SecBot SecBot
SECBOTREPLAY Home › Report › TWST

TWST · Director Katryn Blake filed a Form 144 to sell 2,240 shares of Twist…

Twist Bioscience Corp · 144 filed Aug 12, 2026 at 16:00 ET

At the news

NEUTRALIMPACT 2/10

144 filed Aug 12, 2026 at 16:00 ET

Director Katryn Blake filed a Form 144 to sell 2,240 shares of Twist Bioscience common stock, valued at approximately $275,250. The sale is a tax-withholding transaction tied to the settlement of a vested equity award, not a discretionary portfolio liquidation. Given the small proportional size relative to the company's $8.2B market cap and the tax-motivated nature, this filing carries minimal standalone signal for the stock.

  • Director Katryn Blake filed Form 144 to sell 2,240 shares of Twist Bioscience common stock.
  • The proposed sale value is approximately $275,250.
  • The shares were acquired on 08/05/2026 via Restricted Stock Vesting from the issuer.
  • The filing states the sale is to cover a tax obligation from the settlement of a vested equity award distribution.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access